Tobin Juvenal sold $207K of Castle Biosciences stock
By AlphaYouPublished Form 4
Juvenal Tobin W
Reporting filer
Tobin Juvenal reported selling 6,116 shares of Castle Biosciences Inc for about $207K ($33.77 a share on average). Form 4 filed Nov 12, 2026 lists 2 entries.
See the price move since this trade →
- Disclosed
- Nov 12, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Juvenal Tobin W | 2026-11-09 | S | Sale | 3288 | 32.67 | 35,565 | 3 days | Filed terms
|
| Common Stock | Juvenal Tobin W | 2026-11-11 | S | Sale | 2828 | 35.044 | 32,737 | 1 day | Filed terms
|
Common Stock
- Owner
- Juvenal Tobin W
- Date
- 2026-11-09
- Code
- S
- Action
- Sale
- Quantity
- 3288
- Price
- 32.67
- Following holdings
- 35,565
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-09
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 3288
- transaction Price Per Share: 32.67
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 35565
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Juvenal Tobin W
- Date
- 2026-11-11
- Code
- S
- Action
- Sale
- Quantity
- 2828
- Price
- 35.044
- Following holdings
- 32,737
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-11
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 2828
- transaction Price Per Share: 35.044
- id: F3
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 32737
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Juvenal Tobin W: Chief Commercial Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: This transaction was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 28, 2026.
- F2: This transaction was executed in multiple trades at prices ranging from $32.410 to $33.025, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3: This transaction was executed in multiple trades at prices ranging from $35.000 to $35.105, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Original sources
Prepared automatically from public filing data. Report a correction.